7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Folliculitis decalvans and orofacial granulomatosis

      letter

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Folliculitis decalvans (FD) is a rare and chronic inflammatory dermatosis which pathogenesis remains unclear. It is classified as primary neutrophilic cicatricial alopecia presented clinically with follicular pustules and papules, hemorrhagic crusts, erosions and scarring within scalp. Orofacial granulomatosis (OFG) is a recurrent or persistent orofacial swelling histopathologically presented with non-caseating granulomas. The etiology of the disease is not fully understood. There are hypotheses concerning pathogenesis of the disease including genetic, allergic, infectious and immunological factors. We report a case of a patient with FD and concomitant orofacial granulomatosis successfully treated with dapsone. A 32-year-old man was admitted to the Department of Dermatology to diagnose follicular pustules, erosions, yellow scales, crusts with scarred areas and focal hair loss within the scalp, especially within vertex and accompanying persistent lip swelling with normal appearance of the tongue and no oral lesions (Figure 1). Moreover, we observed erythrosquamous lesions and papules on the lateral surfaces of the trunk, within groins and armpits. The lesions on the scalp occurred in childhood and the lip swelling persisted for 3 years. Except skin eruptions the patient did not report any other complaints. He was initially treated in another clinic for seborrheic dermatitis and acne inversa topically with antibiotics, glucocorticosteroids, tacrolimus and orally with antibiotics (doxycycline), antihistamines with temporary improvement. The patient suffered from post-traumatic epilepsy and was treated with carbamazepine. He had a craniotomy due to head injury (concussions and subdural hematoma of the left temporo-parietal brain region, basilar skull fracture and squamous part of the right temporal bone fracture) during the traffic accident 20 years earlier. During the hospitalization routine laboratory tests showed an elevated C-reactive protein level and erythrocyturia which occurred to be irrelevant (the patient was consulted by the urologist). Swabs from erosions and pustules were collected and two types of bacteria were cultured – Staphylococcus aureus and Streptococcus agalactiae. To exclude concomitant systemic diseases, we performed additional examinations. There were no abnormalities in abdominal ultrasonography or chest X-ray. Antinuclear antibodies, lupus anticoagulant, cardiolipin antibodies (IgG and IgM), β2-glycoprotein 1 antibodies (IgG and IgM), anti-Borrelia spp. antibodies tests (IgG and IgM), concentration of C1 esterase inhibitor and Quantiferon-TB Gold test in patient’s serum were negative or within normal values. Patch tests with 30 allergens were negative in every disc in 48 and 72 h tests. The patient was consulted neurologically to exclude paralysis of the facial nerve, which is one of the symptoms of Melkersson-Rosenthal syndrome. The neurological examination revealed slight features of the central nervous system failure which most likely occurred due to the head injury, there were no signs of facial palsy. Histopathology of the scalp skin lesion revealed absence of hair follicles, epidermal pustules, dermis infiltrations of lymphocytes, plasmocytes and neutrophils, stains for fungi infection were negative (Figure 2 A). Histopathology of the lip showed non-caseating granulomatous inflammation (Figure 2 B). Indirect and direct immunofluorescence were negative. Based on the patient history, physical examination, histopathology and laboratory analysis we identified FD and orofacial granulomatosis. Treatment with dapsone of 100 mg/day combined with topical corticosteroids (betamethasone, clobetasol) and antibiotics (gentamicin, detreomicin) was started and led to significant improvement. Figure 1 A, B – Lesions within scalp, C – persistent lip swelling, D–F – improvement of skin lesions in the course of treatment with dapsone Figure 2 H + E staining. A – Histopathological image of the scalp lesion with epidermal pustules, dermis infiltrations of lymphocytes, plasmocytes and neutrophils, absence of hair follicles, B – histopathological image of the lip showing noncaseating granulomas Folliculitis decalvans mostly occurs in young and middle-aged adults with a slight predilection to men [1]. Its pathogenesis is not clear. Familial cases of the disease were reported [2, 3]. Moreover it seems that the disease is a hypersensitivity reaction to Staphylococcus aureus follicle infection as in majority of patients the bacteria are isolated from lesions as it was in our case [3, 4]. There are single reported cases where the lesions occurred after scalp injuries what may be relevant as our patient had a head injury and craniotomy in the childhood [5, 6]. In majority of cases, FD is clinically presented with pustules, tufted hairs, alopecic patches, erosions and crusts especially within the vertex, what is consistent with our case [1, 3]. Histopathological examination of early lesions reveal papular lesions, perifollicular infiltration mainly consisted of neutrophils lymphocytes and plasma cells and early scarring, in long lasting lesions the infiltration extend deeper into the dermis [1, 3]. The treatment of FD is a challenge because there is no single therapy which leads to long-term remission. In reported cases various therapies were conducted for example systemic antibiotics (especially rifampicin with clindamycin, doxycycline) [3, 7], isotretinoin [8], dapsone [9], frequently in combination with topical corticosteroids and antibiotics. What is important, regular monitoring of the patient is necessary as there are reports on squamous cell carcinoma arising within FD [10]. The term of orofacial granulomatosis was introduced in 1985 by Wiesenfeld et al. to describe idiopathic orofacial edema with granulomatous inflammation in the absence of systemic diseases, what is consistent with our case [11]. Orofacial granulomatosis encompasses other known granulomatous diseases such as Melkersson-Rosenthal syndrome which consists of three symptoms: persistent orofacial edema, recurrent facial paralysis and fissured tongue and Miescher’s cheilitis, which refers to a condition when lip swelling is an isolated symptom or granulomatous cheilitis [12, 13]. Oral granulomas may occur in systemic conditions such as Crohn’s disease, sarcoidosis or tuberculosis so they must be excluded during diagnostic procedures [12]. The etiology of the disease is not fully understood. There are hypotheses concerning pathogenesis of the disease including genetic, allergic (food allergy, allergy to dental materials), infectious (especially tuberculosis) and immunological factors [12]. In our patient we observed erythrosquamous lesions and papules on the lateral surfaces of the trunk, within groins and armpits, what suggested concomitant contact dermatitis although patch tests were negative, further allergy diagnostics would be required. Because etiology of the disease is not clear, the treatment is difficult. When allergy is detected, avoidance of allergens may lead to improvement. In most cases, oral and intralesional corticosteroids were used, moreover there are some reports of topical tacrolimus, clofazimine, thalidomide, dapsone, and infliximab treatment [12–15]. In our case, diagnosis and treatment of two coexisting diseases which etiologies are not fully understood and require multidirectional diagnostic procedures with no single therapies providing satisfying effects was a great challenge. Fortunately, treatment with dapsone combined with topical ointments led to significant improvement.

          Related collections

          Most cited references11

          • Record: found
          • Abstract: found
          • Article: not found

          Folliculitis decalvans including tufted folliculitis: clinical, histological and therapeutic findings.

          In a series of 18 patients with folliculitis decalvans attending the Oxford hair clinic, eight were found to have areas of tufted folliculitis either at presentation or follow-up. There was no difference between these two groups in their presentation, clinical course, growth of causative organism (Staphylococcus aureus) or investigations including histology. We suggest that these two entities form part of a spectrum of a single disease. We performed lymphocyte staining on affected scalp biopsies, including CD4: CD8 and T-cell/B-cell ratios, but found no evidence of local immune suppression or failure which would explain the abnormal host response to a common pathogen in this rare condition. We introduced a new treatment regimen for these patients, oral rifampicin and oral clindamycin together for 10 weeks. Ten of the 18 patients have responded well with no evidence of recurrence 2-22 months after one course of treatment, and 15 of the 18 responded after two or three courses.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Folliculitis decalvans.

            Folliculitis decalvans is a rare inflammatory scalp disorder. The present paper gives a practical approach to diagnosis and patient management and reviews possible pathogenetic factors and treatment options. Folliculitis decalvans is classified as primary neutrophilic cicatricial alopecia and predominantly occurs in middle-aged adults. Staphylococcus aureus and a deficient host immune response seem to play an important role in the development of this disfiguring scalp disease. Lesions occur mainly in the vertex and occipital area. Clinically, the lesions present with follicular pustules, lack of ostia, diffuse and perifollicular erythema, follicular tufting, and, oftentimes, hemorrhagic crusts and erosions. Histology displays a mainly neutrophilic inflammatory infiltrate in early lesions and additionally lymphocytes and plasma cells in advanced lesions. Treatment is focused on the eradication of S. aureus anti-inflammatory agents.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Folliculitis decalvans: a multicentre review of 82 patients.

              Folliculitis decalvans (FD) is a rare neutrophilic scarring alopecia that represents a therapeutic challenge for dermatologists.
                Bookmark

                Author and article information

                Journal
                Postepy Dermatol Alergol
                Postepy Dermatol Alergol
                PDIA
                Advances in Dermatology and Allergology/Postȩpy Dermatologii i Alergologii
                Termedia Publishing House
                1642-395X
                2299-0046
                18 June 2018
                June 2018
                : 35
                : 3
                : 317-319
                Affiliations
                [0001]Clinic of Dermatology, Sexually Transmitted Diseases and Immunodermatology, Faculty of Medicine in Bydgoszcz, Nicolaus Copernicus University in Torun, Poland
                Author notes
                Address for correspondence: Kaja Męcińska-Jundziłł MD, Clinic of Dermatology, Sexually Transmitted Diseases and Immunodermatology, Faculty of Medicine, Nicolaus Copernicus University, 9 Sklodowskiej-Curie St, 85-094 Bydgoszcz, Poland, phone: +48 602 404 829, e-mail: kaja_cm@ 123456wp.pl
                Article
                30654
                10.5114/pdia.2017.70261
                6041710
                067e416b-75cf-4184-8153-357ae42e9a02
                Copyright: © 2018 Termedia Sp. z o. o.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

                History
                : 11 June 2017
                : 12 August 2017
                Categories
                Letter to the Editor

                Comments

                Comment on this article